On its way to making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO
Hong Kong’s stock exchange will induct its first pre-revenue biotech as early as August 1, as Ascletis finalizes its plans to raise as much as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
